A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ

Yanjun Zhao, Mojgan Moddaresi, Stuart A. Jones, Marc Brown

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Abstract

Topical nanoparticles are usually applied using semi-solid formulations, but the delivery process is often inefficient due to the poor drug release from the particles. The aim of this study was to investigate the capability of a dynamic foam to break open nanoparticles upon application to the skin and enhance drug delivery efficiency. Vitamin E acetate (VEAc) was selected as a model drug and loaded into lipid nanoparticles (50-60 nm) prepared by phase inversion. The highest drug loading was 18.9 +/- 1.2 mg/ml and the corresponding encapsulation efficiency was 81.5 +/- 4.1 %. Dynamic foams were generated by emulsifying VEAc-loaded nanoparticle Suspensions with hydrofluoroalkane using pluronic L62D. Ail in vitro permeation study demonstrated that VEAc did not release from the nanoparticles when administered as ail aqueous Suspension, but attained a flux of 18.0 +/- 2.1 (mu g cm(-2) h(-1)) when applied using the foam. Drug release from the foam was shown to be a consequence of nanoparticle modification after dose administration and this led to the foam delivering 0.7 +/- 0.3% VEAc into the stratum corneum (SC) when applied to human skin. (C) 2009 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)521-528
Number of pages8
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume72
Issue number3
DOIs
Publication statusPublished - Aug 2009

Keywords

  • Foam
  • Vehicle
  • Vitamin E acetate
  • Nanoparticle
  • Penetration
  • SOLID LIPID NANOPARTICLES
  • OXIDE) TRIBLOCK COPOLYMERS
  • PERCUTANEOUS-ABSORPTION
  • DELIVERY SYSTEMS
  • VITAMIN-E
  • SKIN
  • ENHANCEMENT
  • PENETRATION
  • FORMULATION
  • PERMEATION

Fingerprint

Dive into the research topics of 'A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ'. Together they form a unique fingerprint.

Cite this